Nevertheless, preliminary data suggested a significant relationship between PD-L1 expression, clinical outcome, radiation response and therapeutic response to immunotherapy in bladder cancer [2, 9, 28, 37]. This evidence concerns the gene CD274 and urinary bladder cancer.